Solid Tumor Testing Market Size Outlook and Demand Growth Across 2026–2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Solid Tumor Testing Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The solid tumor testing market size has experienced robust expansion in recent years. This market is projected to expand from $29.94 billion in 2025 to $32.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. Historically, this growth has been driven by advances in cancer diagnostics, biomarker discovery, pathology automation, oncology awareness, and screening initiatives.

The solid tumor testing market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $43.19 billion, exhibiting a compound annual growth rate (CAGR) of 7.7%. This forecasted development is primarily driven by factors such as the increasing demand for personalized treatments, a heightened focus on early detection, the expansion of genomic testing, the emergence of AI-driven diagnostics, and the overall growth in oncology research. Key trends expected during this period involve the rising prevalence of liquid biopsy testing, wider adoption of next-generation sequencing, the broadening scope of companion diagnostics, the integration of AI in pathology, and an increase in screening initiatives.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

What Drivers Are Influencing The Solid Tumor Testing Market?

The anticipated rise in cancer cases is projected to drive the expansion of the solid tumor testing market in the future. Cancer is characterized by the uncontrolled proliferation and dissemination of aberrant cells within the body. These malignant cells, referred to as cancer cells, possess the ability to infiltrate nearby tissues and organs, sometimes spreading to other parts of the body through the bloodstream or lymphatic system. A significant majority, approximately 90%, of adult cancers are solid tumors. Solid tumor testing is employed to detect cancer cells in the blood of patients with solid tumors, even if the cancer is not yet visible on imaging tests. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 165,000 Australians were newly diagnosed with cancer in 2023, which equates to over 450 cases each day, and males represented about 55% of these diagnoses. Therefore, the increasing prevalence of cancer is driving the growth of the solid tumor testing market.

What Major Segment Divisions Exist Within The Solid Tumor Testing Market?

The solid tumor testing market covered in this report is segmented –

1) By Type: Genetic Testing, Conventional Testing

2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer

3) By Application: Clinical, Research

4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

Subsegments:

1) By Genetic Testing: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH)

2) By Conventional Testing: Histopathology, Cytology, Imaging Techniques

What Trends Are Affecting The Expansion Of The Solid Tumor Testing Market?

Companies operating in the solid tumor testing market are focusing on developing innovations such as liquid biopsy platforms for solid tumor testing. A liquid biopsy platform includes various technologies and systems used to analyze body fluids, typically blood, for cancer-related biomarkers. For instance, in January 2023, PrognomiQ, a US-based healthcare company, launched its multi-omics liquid biopsy platform. PrognomiQ’s next phase of product development has begun with the initiation of a 15,000-subject prospective clinical program, which has enrolled its first patient. This initiative was spurred by the potential of multi-omics markers to distinguish between cancer and controls.

Which Companies Are Leading Innovation In The Solid Tumor Testing Market?

Major companies operating in the solid tumor testing market are Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company BD, Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Anixa Biosciences Inc., Cellular Biomedicine Group

Read the full solid tumor testing market report here:

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Solid Tumor Testing Market?

North America was the largest region in the solid tumor testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Solid Tumor Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp

Browse Through More Reports Similar to the Global Solid Tumor Testing Market 2026, By The Business Research Company

Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Solid Tumor Cancer Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Hemato Oncology Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795